William Blair equity research analyst Louie DiPalma was a guest on Bloomberg Tech for a story on SpaceX’s post-IPO quiet period, its competitive landscape, and the future of the company.
Equity Research
Louie DiPalma Featured on Bloomberg Tech
Delivered to Your Inbox
Stay up-to-date with the latest William Blair news and insights
Our Latest News
-
Zentalis Pharmaceuticals, Inc.: Initiation of Research Coverage
William Blair initiated research coverage of Zentalis Pharmaceuticals, Inc. (ZNTL $3.50), a clinical-stage biotech company focused on developing azenosertib, a small-molecule WEE1 inhibitor, for the treatment of ovarian cancer and other tumors.
-
-
The Metals Royalty Company Inc.: Initiation of Research Coverage
William Blair initiated research coverage of The Metals Royalty Company Inc. (TMCR $5.41). The Metals Royalty Company is focused on acquiring critical metals and energy royalty interests that support U.S. mineral security, with key royalties in the NORI and Mesabi projects.